Coproporphyria hereditariaE80.2

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Berger and Goldberg, 1955

DefinitionThis section has been translated automatically.

Rare form of autosomal dominant inherited hepatic porphyria. S.a. Coproporphyria symptomatica.

Occurrence/EpidemiologyThis section has been translated automatically.

Prevalence: 0.1-0.4/100,000 inhabitants.

EtiopathogenesisThis section has been translated automatically.

Autosomal-dominantly inherited mutations of the CPO gene (coproporphyrinogen oxidase gene; gene locus: 3q12), which leads to a partial insufficiency of coproporphyrinogen oxidase.

ManifestationThis section has been translated automatically.

Very rarely before puberty; mostly 18th-40th LJ. Neonatal-onset is described sporadically in casuistics.

Clinical featuresThis section has been translated automatically.

Cutaneous and neurovisceral symptoms.
  • Integument: Reddish-livid, succulent, itchy infiltrates or persistent, livid erythema and blistering of the back of the hand after sun exposure. S.u. Porphyria cutanea tarda.
  • Extracutaneous manifestations: including colicky epigastric abdominal pain (often lasting several days). Frequent tachycardia, high blood pressure and neurological dysfunctions such as seizures, visual disturbances or motor neuropathies that usually start in the lower extremity. Rare: Interstitial nephritis.

LaboratoryThis section has been translated automatically.

Large amounts of coproporphyrin III in stool and urine.

TherapyThis section has been translated automatically.

Therapy of acute symptoms, see below Porphyria syndrome, acute. Prophylactic textile and chemical/physical light protection (see also light protection agents), if necessary reversal of the day-night rhythm. S.a. Porphyria cutanea tarda.

LiteratureThis section has been translated automatically.

  1. Berger H, Goldberg A (1955) Hereditary coproporphyria. BMJ 2: 85-88
  2. Gross U et al (2002) A molecular, enzymatic and clinical study in a family with hereditary coproporphyria. J Inherit Metab Dis 25: 279-286
  3. Kuhnel A et al (2000) Hereditary coproporphyria in Germany: clinical-biochemical studies in 53 patients. Clin Biochem 33: 465-473
  4. Lecha M et al (2003) Diagnosis and treatment of the hepatic porphyrias. Dermatol Ther 16: 65-72
  5. Takeuchi H et al (2001) Neonatal-onset hereditary coproporphyria with male pseudohermaphrodism. Blood 98: 3871-3373

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer